dsm-firmenich share repurchase program progress
Analysis based on 8 articles · First reported Aug 25, 2026 · Last updated Sep 01, 2026
The ongoing share repurchase program is likely to support dsm-firmenich's share price by reducing the number of outstanding shares and signaling management's confidence in the company's cash flow. The program is part of a broader capital return strategy, which may be viewed positively by investors, though the impact is modest given the routine nature of the buyback.
dsm-firmenich, a Swiss-based nutrition, health, and beauty company, is executing a share repurchase program announced on February 9, 2026. The program aims to repurchase ordinary shares with an aggregate market value of €500 million to reduce issued capital, plus an additional €40 million to cover share-based compensation plans. The company commenced repurchases on March 12, 2026, and the €40 million compensation-related buyback was completed on March 23, 2026. As of the latest weekly update (August 28, 2026), the company has repurchased a total of 5,742,212 shares at an average price of €70.59, for a total consideration of €405.4 million. The €500 million capital reduction program is expected to be completed by the end of Q3 2026. The company is listed on Euronext Amsterdam and SIX Swiss Exchange.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard